218 related articles for article (PubMed ID: 32297570)
1. Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.
Carneiro VA; de Oliveira ST; Silva RL; de Sousa Duarte H; Silva ML; Matos MNC; Cavalcante RMB; Figueira CS; Lorenzón EN; Cilli EM; da Cunha RMS
Protein Pept Lett; 2020; 27(11):1124-1131. PubMed ID: 32297570
[TBL] [Abstract][Full Text] [Related]
2. Activity of Antimicrobial Peptides and Ciprofloxacin against
Yasir M; Dutta D; Willcox MDP
Molecules; 2020 Aug; 25(17):. PubMed ID: 32847059
[No Abstract] [Full Text] [Related]
3. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
4. Himatanthus drasticus Leaves: Chemical Characterization and Evaluation of Their Antimicrobial, Antibiofilm, Antiproliferative Activities.
Figueiredo CSSES; Branco Santos JC; Castro Junior JAA; Wakui VG; Rodrigues JFS; Arruda MO; Monteiro AS; Monteiro-Neto V; Bomfim MRQ; Kato L; Nascimento da Silva LC; Grisotto MAG
Molecules; 2017 May; 22(6):. PubMed ID: 28561790
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
Tewes F; Bahamondez-Canas TF; Smyth HDC
AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
[TBL] [Abstract][Full Text] [Related]
6. Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa.
Bessa LJ; Eaton P; Dematei A; Plácido A; Vale N; Gomes P; Delerue-Matos C; Sa Leite JR; Gameiro P
Future Microbiol; 2018 Feb; 13():151-163. PubMed ID: 29308671
[TBL] [Abstract][Full Text] [Related]
7. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
[TBL] [Abstract][Full Text] [Related]
9. Permeability enhancers sensitize β-lactamase-expressing Enterobacteriaceae and Pseudomonas aeruginosa to β-lactamase inhibitors, thereby restoring their β-lactam susceptibility.
Ferrer-Espada R; Sánchez-Gómez S; Pitts B; Stewart PS; Martínez-de-Tejada G
Int J Antimicrob Agents; 2020 Jul; 56(1):105986. PubMed ID: 32335279
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
Ahire JJ; Neveling DP; Hattingh M; Dicks LM
PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
Zhao T; Liu Y
BMC Microbiol; 2010 May; 10():140. PubMed ID: 20462423
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
Dosler S; Karaaslan E; Alev Gerceker A
J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
[TBL] [Abstract][Full Text] [Related]
15. Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms.
Hacioglu M; Oyardi O; Bozkurt-Guzel C; Savage PB
J Antibiot (Tokyo); 2020 Jul; 73(7):455-462. PubMed ID: 32203127
[TBL] [Abstract][Full Text] [Related]
16. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
17. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
[TBL] [Abstract][Full Text] [Related]
19. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
20. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa.
Martinez M; Gonçalves S; Felício MR; Maturana P; Santos NC; Semorile L; Hollmann A; Maffía PC
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1329-1337. PubMed ID: 31095945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
